FaF:FAFO2_13 Dosage Forms and Biopharmacy - Informace o předmětu
FAFO2_13 Dosage Forms and Biopharmacy II
Farmaceutická fakultajaro 2024
- Rozsah
- 3/6/0. 11 kr. Ukončení: zk.
- Vyučující
- doc. PharmDr. Aleš Franc, Ph.D. (přednášející)
doc. PharmDr. Jan Gajdziok, Ph.D. (přednášející)
doc. PharmDr. Kateřina Kubová, Ph.D. (přednášející)
PharmDr. Jakub Vysloužil, Ph.D. (přednášející)
doc. PharmDr. Aleš Franc, Ph.D. (cvičící)
doc. PharmDr. Jan Gajdziok, Ph.D. (cvičící)
doc. PharmDr. Kateřina Kubová, Ph.D. (cvičící)
PharmDr. Jakub Vysloužil, Ph.D. (cvičící)
prof. PharmDr. Mgr. David Vetchý, Ph.D. (přednášející)
PharmDr. Kateřina Brückner, Ph.D. (cvičící)
PharmDr. Miroslava Pavelková, Ph.D. (cvičící)
PharmDr. Jiří Zeman, Ph.D. (cvičící) - Garance
- doc. PharmDr. Kateřina Kubová, Ph.D.
Ústav farmaceutické technologie – Ústavy – Farmaceutická fakulta - Rozvrh
- Čt 9:15–11:45 18-122
- Rozvrh seminárních/paralelních skupin:
- Předpoklady
- FAFO1_13 Dosage Forms and Biopharmacy
Dosage Forms and Biopharmacy I
Students can study this course only after completing the course Dosage Forms and Biopharmacy I - Omezení zápisu do předmětu
- Předmět je určen pouze studentům mateřských oborů.
Předmět si smí zapsat nejvýše 20 stud.
Momentální stav registrace a zápisu: zapsáno: 7/20, pouze zareg.: 0/20 - Mateřské obory/plány
- Multidisciplinární studia na farmaceutické fakultě (program CST, KOS)
- Pharmacy (program FaF, M-FARMA)
- Cíle předmětu
- One of the main obligatory pharmaceutical disciplines dealing with preparation, manufacturing and quality control of medicaments including technological procedures, equiment, excipients and appropriate analytical devices. It covers the influence of the application form on drug bioavailability.
- Výstupy z učení
- After completing the course, the student will:
- describe the theoretical aspects of semisolid dosage forms formulation and quality testing;
- describe the classification, requirements, excipients, and technological process of preparation and production of solid dosage forms, including their evaluation;
- theoretically describe the classification, requirements, excipients, technological process of preparation and production of dosage forms with controlled drug release, including their evaluation;
- know the basic aspects of semisolid and solid dosage forms about the drug bioavailability;
- describe the main conditions of GMP
- recognize selected incompatibilities in liquid and semisolid dosage forms and adjust the composition of pharmaceutical products;
- prepare semisolid (ointments, cremes, pastes, gels) and solid dosage forms (powders, granules, capsules, suppositories, vaginal globules) in pharmacy conditions - Osnova
- Topic of lecture
Dosage forms for rectal application
Dosage forms for vaginal application
Granules, granulation methods. Evaluation of powders and granules
Tablets, their production, and evaluation
Pharmaceutical packaging
Pharmaceutical incompatibilities in dosage forms
Coated products, their production and evaluation
Development of new drugs from galenical perspective
Multiple-unit drug delivery systems
Pharmaceutical aerodispersions
Transdermal preparations
Validation in pharmaceutical technology
Controlled drug release
Good manufacturing practice in pharmacy
Practical labs
Semisolid dosage forms - Ointments
Semisolid dosage forms - Creams
Semisolid dosage forms - Pastes, Gels
Test - semisolid preparation. Rectal and vaginal dosage forms - theoretical aspect of preparation
Rectal and vaginal dosage forms
Technological processes in preparation of difficult prescriptions I. Test - suppositories, vaginal globules.
Technological processes in preparation of difficult prescriptions II.
Divided and non-divided pharmaceutical powders. Preparation and evaluation
Alternative training
Wet and melt granulations
Tablets preparation by direct compression
Evaluation of solid dosage forms
Fluid bed granulation
Credit test, Laboratory skills testing
- Topic of lecture
- Literatura
- povinná literatura
- KUBOVÁ, Kateřina, Aleš FRANC, Jan GAJDZIOK, Martina KEJDUŠOVÁ a David VETCHÝ. Medical forms and biopharmacy - I. Liquid and Semi-Solid Dosage Forms. 1. vyd. Brno: Farmaceutická fakulta Veterinární a farmaceutické univerzity, 2014, 125 s. ISBN 978-80-7305-671-1. URL info
- KUBOVÁ, Kateřina, Aleš FRANC, Jan GAJDZIOK, Martina KEJDUŠOVÁ a David VETCHÝ. Medical forms and biopharmacy - II. Solid Dosage Forms. Brno: Farmaceutická fakulta Veterinární a farmaceutické univerzity, 2014, 87 s. skripta. ISBN 978-80-7305-757-2. URL info
- The texts which are available during the lectures. info
- doporučená literatura
- European Pharmacopoeia 11
- MAHATO, Ram I. Pharmaceutical dosage forms and drug delivery. Boca Raton, FL: CRC Press, 2007, xxxi, 300. ISBN 0849392853. info
- Aqueous polymeric coatings for pharmaceutical dosage forms. Edited by Linda A. Felton. Fourth edition. Boca Raton, FL: CRC Press, 2017, 1 online. ISBN 9781315369938. URL info
- Handbook of Pharmaceutical Excipients. Great Britain, 2006. ISBN 1-58212-058-7. info
- Výukové metody
- 1Lectures - powerpoint presentations
2 Individual lab training - practical skills - Metody hodnocení
- Intermediate tests in laboratory classes
Systematic observation of the student during laboratory classes, preparation of reports following the teacher's instructions
Credit test (credit test has two parts, part 1 - pharmaceutical calculations (limit for passing 75%), part 2 - test - closed and open questions from knowledge from lectures and laboratory classes (limit for passing - 60%).
Practical testing is conducted to evaluate students' skills as part of the credit assessment.
Oral examination (study topics are available in the study materials in IS MU) - Vyučovací jazyk
- Angličtina
- Informace učitele
- Lectures are recommended due to the lack of suitable literature. Students can study this course only after completing the course Dosage Forms and Biopharmacy I
All study materials are available in IS MU. - Další komentáře
- Studijní materiály
Předmět je dovoleno ukončit i mimo zkouškové období.
- Statistika zápisu (nejnovější)
- Permalink: https://is.muni.cz/predmet/pharm/jaro2024/FAFO2_13